|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6303347B1
(en)
|
1997-05-08 |
2001-10-16 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US7063967B2
(en)
|
1997-05-08 |
2006-06-20 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6764840B2
(en)
|
1997-05-08 |
2004-07-20 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US7541020B2
(en)
*
|
1997-05-08 |
2009-06-02 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
AU773921B2
(en)
*
|
1997-05-08 |
2004-06-10 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US7087713B2
(en)
*
|
2000-02-25 |
2006-08-08 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
CA2767116A1
(en)
|
1999-05-13 |
2000-11-23 |
Wyeth Holdings Corporation |
Adjuvant combination formulations
|
|
AU779978B2
(en)
*
|
1999-10-07 |
2005-02-24 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
KR20090085697A
(ko)
|
2000-02-23 |
2009-08-07 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
종양 특이적 동물 단백질
|
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
|
US6699846B2
(en)
*
|
2000-03-17 |
2004-03-02 |
Corixa Corporation |
Mono- and disaccharides for the treatment of nitric oxide related disorders
|
|
WO2001078777A2
(en)
*
|
2000-04-13 |
2001-10-25 |
Mossman, Sally |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21
|
|
PT1284740E
(pt)
*
|
2000-05-19 |
2008-07-09 |
Corixa Corp |
Tratamento profiláctico e terapêutico de doenças infecciosas, autoimunes e alérgicas com compostos à base de monossacáridos
|
|
US20030139356A1
(en)
*
|
2001-05-18 |
2003-07-24 |
Persing David H. |
Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
|
|
US20030105032A1
(en)
*
|
2000-05-19 |
2003-06-05 |
Persing David H. |
Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
|
|
ES2333579T3
(es)
*
|
2000-06-20 |
2010-02-24 |
Corixa Corporation |
Proteinas de fusion de mycobacterium tuberculosis.
|
|
ES2261453T3
(es)
|
2000-08-04 |
2006-11-16 |
Corixa Corporation |
Nuevos compuestos inmunoefectores.
|
|
IL155690A0
(en)
|
2000-11-10 |
2003-11-23 |
Wyeth Corp |
Adjuvant combination formulations
|
|
US20060142202A1
(en)
*
|
2000-12-08 |
2006-06-29 |
3M Innovative Properties Company |
Compositions and methods for targeted delivery of immune response modifiers
|
|
CN100422210C
(zh)
|
2000-12-28 |
2008-10-01 |
Wyeth公司 |
来自肺炎链球菌的重组防护蛋白质
|
|
IL158328A0
(en)
*
|
2001-04-13 |
2004-05-12 |
Wyeth Corp |
Surface proteins of streptococcus pyogenes
|
|
US20070128229A1
(en)
*
|
2002-04-12 |
2007-06-07 |
Wyeth |
Surface proteins of Streptococcus pyogenes
|
|
WO2002083855A2
(en)
|
2001-04-16 |
2002-10-24 |
Wyeth Holdings Corporation |
Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
|
|
JP2005504513A
(ja)
|
2001-05-09 |
2005-02-17 |
コリクサ コーポレイション |
前立腺癌の治療及び診断のための組成物及び方法
|
|
US7361352B2
(en)
|
2001-08-15 |
2008-04-22 |
Acambis, Inc. |
Influenza immunogen and vaccine
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
CN1301134C
(zh)
*
|
2002-02-04 |
2007-02-21 |
科里克萨有限公司 |
新的免疫效应化合物
|
|
US7030094B2
(en)
*
|
2002-02-04 |
2006-04-18 |
Corixa Corporation |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21
|
|
IL163305A
(en)
*
|
2002-02-04 |
2010-10-31 |
Corixa Corp |
Azacycloalkyl glucosaminide phosphate as immunoeffector compounds and pharmaceutical compositions for propylactic and therapeutic treatment of infectious and therapeutic treatment of infectious and other diseases comprising the same
|
|
US20030190333A1
(en)
*
|
2002-02-04 |
2003-10-09 |
Corixa Corporation |
Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
|
|
US6911434B2
(en)
*
|
2002-02-04 |
2005-06-28 |
Corixa Corporation |
Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
|
|
AU2003213118A1
(en)
*
|
2002-02-15 |
2003-09-09 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
US7351413B2
(en)
*
|
2002-02-21 |
2008-04-01 |
Lorantis, Limited |
Stabilized HBc chimer particles as immunogens for chronic hepatitis
|
|
NZ534566A
(en)
*
|
2002-02-22 |
2007-02-23 |
3M Innovative Properties Co |
Method of reducing and treating UVB-induced immunosuppression
|
|
WO2003073827A2
(en)
*
|
2002-02-28 |
2003-09-12 |
Corixa Corporation |
Methods of modulating dendritic cells using adjuvants
|
|
WO2003078453A1
(en)
|
2002-03-15 |
2003-09-25 |
Wyeth Holdings Corporation |
Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
|
|
ES2343788T3
(es)
|
2002-05-09 |
2010-08-10 |
Oncothyreon Inc. |
Analogos de lipido a y de otros ligandos glucidicos.
|
|
US7288640B2
(en)
*
|
2002-07-08 |
2007-10-30 |
Corixa Corporation |
Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
|
|
MXPA05000407A
(es)
*
|
2002-07-08 |
2005-04-19 |
Corixa Corp |
Procedimientos para la produccion de fosfato de aminoalquilglucosaminida e inmunoefectores de disacarido, e intermediarios para los mismos.
|
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
US7301554B2
(en)
*
|
2002-09-20 |
2007-11-27 |
Ricoh Company, Ltd. |
Light scanning device, scanning line adjusting method, scanning line adjusting control method, image forming apparatus, and image forming method
|
|
AU2003300184B8
(en)
*
|
2002-12-30 |
2009-12-03 |
3M Innovative Properties Company |
Immunostimulatory combinations
|
|
ES2639812T3
(es)
*
|
2003-01-06 |
2017-10-30 |
Corixa Corporation |
Ciertos compuestos de fosfato de aminoalquil glucosaminida y sus usos
|
|
US7960522B2
(en)
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
|
EP1592302A4
(en)
*
|
2003-02-13 |
2007-04-25 |
3M Innovative Properties Co |
METHODS AND COMPOSITIONS ASSOCIATED WITH IMMUNE RESPONSE MODIFIER COMPOUNDS AND TOLL-LIKE RECEPTOR 8
|
|
EP1599726A4
(en)
*
|
2003-02-27 |
2009-07-22 |
3M Innovative Properties Co |
SELECTIVE MODULATION OF TLR-MEDIATED BIOLOGICAL ACTIVITY
|
|
US8110582B2
(en)
|
2003-03-04 |
2012-02-07 |
3M Innovative Properties Company |
Prophylactic treatment of UV-induced epidermal neoplasia
|
|
MXPA05009694A
(es)
*
|
2003-03-13 |
2005-10-20 |
3M Innovative Properties Co |
Metodos para mejorar la calidad de la piel.
|
|
WO2004080292A2
(en)
|
2003-03-13 |
2004-09-23 |
3M Innovative Properties Company |
Method of tattoo removal
|
|
US20040192585A1
(en)
*
|
2003-03-25 |
2004-09-30 |
3M Innovative Properties Company |
Treatment for basal cell carcinoma
|
|
AU2004244962A1
(en)
*
|
2003-04-10 |
2004-12-16 |
3M Innovative Properties Company |
Delivery of immune response modifier compounds using metal-containing particulate support materials
|
|
US20040265351A1
(en)
*
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
|
AU2004264330A1
(en)
*
|
2003-08-05 |
2005-02-24 |
3M Innovative Properties Company |
Infection prophylaxis using immune response modifier compounds
|
|
US7648997B2
(en)
|
2003-08-12 |
2010-01-19 |
Coley Pharmaceutical Group, Inc. |
Hydroxylamine substituted imidazoquinolines
|
|
JP2007504145A
(ja)
*
|
2003-08-25 |
2007-03-01 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫刺激性の組み合わせおよび治療
|
|
NZ545412A
(en)
|
2003-08-27 |
2008-12-24 |
Coley Pharm Group Inc |
Aryloxy and arylalkyleneoxy substituted imidazoquinolines
|
|
US20050054665A1
(en)
*
|
2003-09-05 |
2005-03-10 |
3M Innovative Properties Company |
Treatment for CD5+ B cell lymphoma
|
|
BRPI0414856A
(pt)
|
2003-10-03 |
2006-11-21 |
3M Innovative Properties Co |
imidazoquinolinas alcóxi-substituìdas
|
|
US7544697B2
(en)
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
|
EP1680080A4
(en)
*
|
2003-10-31 |
2007-10-31 |
3M Innovative Properties Co |
NEUTROPHILIC ACTIVATION THROUGH COMPOUNDS TO MODIFY THE IMMUNE RESPONSE
|
|
US7897767B2
(en)
|
2003-11-14 |
2011-03-01 |
3M Innovative Properties Company |
Oxime substituted imidazoquinolines
|
|
CN1906192A
(zh)
|
2003-11-14 |
2007-01-31 |
3M创新有限公司 |
羟胺取代的咪唑环化合物
|
|
KR101130928B1
(ko)
|
2003-11-25 |
2012-04-12 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
치환된 이미다조 고리 시스템 및 방법
|
|
US8940755B2
(en)
*
|
2003-12-02 |
2015-01-27 |
3M Innovative Properties Company |
Therapeutic combinations and methods including IRM compounds
|
|
US20050226878A1
(en)
*
|
2003-12-02 |
2005-10-13 |
3M Innovative Properties Company |
Therapeutic combinations and methods including IRM compounds
|
|
MY144231A
(en)
|
2003-12-17 |
2011-08-15 |
Wyeth Corp |
Aß IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME
|
|
EA012984B1
(ru)
|
2003-12-17 |
2010-02-26 |
Вайет |
Конъюгаты иммуногенных пептидных носителей и способы их получения
|
|
EP1701955A1
(en)
|
2003-12-29 |
2006-09-20 |
3M Innovative Properties Company |
Arylalkenyl and arylalkynyl substituted imidazoquinolines
|
|
WO2005066169A2
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
|
|
JP2007517055A
(ja)
*
|
2003-12-30 |
2007-06-28 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答の増強
|
|
US8697873B2
(en)
|
2004-03-24 |
2014-04-15 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
|
US20060051374A1
(en)
*
|
2004-04-28 |
2006-03-09 |
3M Innovative Properties Company |
Compositions and methods for mucosal vaccination
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
JP2008502363A
(ja)
|
2004-05-21 |
2008-01-31 |
ワイス |
Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓの改変型フィブロネクチン結合タンパク質
|
|
US20050267145A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Merrill Bryon A |
Treatment for lung cancer
|
|
US8017779B2
(en)
|
2004-06-15 |
2011-09-13 |
3M Innovative Properties Company |
Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
|
TW200613554A
(en)
|
2004-06-17 |
2006-05-01 |
Wyeth Corp |
Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
|
|
WO2006038923A2
(en)
|
2004-06-18 |
2006-04-13 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
|
US8026366B2
(en)
|
2004-06-18 |
2011-09-27 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
|
WO2006065280A2
(en)
|
2004-06-18 |
2006-06-22 |
3M Innovative Properties Company |
Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
|
|
WO2006026470A2
(en)
*
|
2004-08-27 |
2006-03-09 |
3M Innovative Properties Company |
Hiv immunostimulatory compositions
|
|
US20070243215A1
(en)
*
|
2004-10-08 |
2007-10-18 |
Miller Richard L |
Adjuvant for Dna Vaccines
|
|
CN101175508A
(zh)
|
2004-10-21 |
2008-05-07 |
惠氏公司 |
表皮葡萄球菌多肽抗原的免疫原性组合物
|
|
JP5543068B2
(ja)
|
2004-12-30 |
2014-07-09 |
スリーエム イノベイティブ プロパティズ カンパニー |
キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
|
|
SI1830876T1
(sl)
|
2004-12-30 |
2015-08-31 |
Meda Ab |
Uporaba imikvimoda za zdravljenje kožnih metastaz, ki izhajajo iz rakavega tumorja dojke
|
|
ES2392648T3
(es)
|
2004-12-30 |
2012-12-12 |
3M Innovative Properties Company |
Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
|
|
JP2008530022A
(ja)
|
2005-02-04 |
2008-08-07 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
免疫反応調節物質を含む水性ゲル処方物
|
|
WO2006086634A2
(en)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
|
|
JP2008538550A
(ja)
|
2005-04-01 |
2008-10-30 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての１−置換ピラゾロ（３，４−ｃ）環状化合物
|
|
EP1869043A2
(en)
|
2005-04-01 |
2007-12-26 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridine-1,4-diamines and analogs thereof
|
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
IL308456A
(en)
|
2005-04-08 |
2024-01-01 |
Wyeth Llc |
A multivalent pneumomuroral protein-polysaccharide conjugate preparation
|
|
CA2605808A1
(en)
*
|
2005-04-25 |
2006-11-02 |
3M Innovative Properties Company |
Immunostimulatory compositions
|
|
US20080213318A1
(en)
*
|
2005-07-05 |
2008-09-04 |
Hawaii Biotech, Inc. |
Malaria MSP-1 C-terminal enhanced subunit vaccine
|
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
PT1962899E
(pt)
|
2005-12-22 |
2011-10-19 |
Glaxosmithkline Biolog Sa |
Vacina conjugada polissacarídica pneumocócica
|
|
WO2007100634A2
(en)
|
2006-02-22 |
2007-09-07 |
3M Innovative Properties Company |
Immune response modifier conjugates
|
|
EA020459B1
(ru)
|
2006-03-30 |
2014-11-28 |
Глаксосмитклайн Байолоджикалс С.А. |
Иммуногенная композиция
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
KR20090017655A
(ko)
|
2006-06-02 |
2009-02-18 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
환자가 면역치료제에 대한 반응자일지의 여부를 확인하는 방법
|
|
WO2008008432A2
(en)
|
2006-07-12 |
2008-01-17 |
Coley Pharmaceutical Group, Inc. |
Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
|
|
EA200900033A1
(ru)
|
2006-07-18 |
2009-12-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Вакцины против малярии
|
|
US8323664B2
(en)
|
2006-07-25 |
2012-12-04 |
The Secretary Of State For Defence |
Live vaccine strains of Francisella
|
|
EP2086582B1
(en)
|
2006-10-12 |
2012-11-14 |
GlaxoSmithKline Biologicals s.a. |
Vaccine comprising an oil in water emulsion adjuvant
|
|
US20090285819A1
(en)
*
|
2006-11-15 |
2009-11-19 |
Functional Genetics, Inc. |
Methods and compositions for treating influenza
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
US20080149123A1
(en)
|
2006-12-22 |
2008-06-26 |
Mckay William D |
Particulate material dispensing hairbrush with combination bristles
|
|
MX362698B
(es)
|
2007-03-02 |
2019-02-01 |
Glaxosmithkline Biologicals Sa |
Metodo novedoso y composiciones.
|
|
PL2136836T3
(pl)
|
2007-04-04 |
2017-07-31 |
Infectious Disease Research Institute |
Kompozycje immunogenne zawierające polipeptydy prątka gruźlicy i produkty ich fuzji
|
|
TW200908994A
(en)
|
2007-04-20 |
2009-03-01 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
BRPI0813644B8
(pt)
|
2007-06-26 |
2021-05-25 |
Glaxosmithkline Biologicals Sa |
composição imunogênica, vacina, processo para fabricar a mesma, e, uso da composição imunogênica ou vacina
|
|
DK2173376T3
(en)
*
|
2007-08-02 |
2015-06-29 |
Biondvax Pharmaceuticals Ltd |
Multimeric multi-epitope influenza vaccines
|
|
WO2009037438A1
(en)
|
2007-09-17 |
2009-03-26 |
Oncomethylome Sciences Sa |
Improved detection of mage-a expression
|
|
US20090215710A1
(en)
*
|
2007-09-24 |
2009-08-27 |
Reliance Life Sciences Pvt. Ltd. |
Carbohydrate based toll-like receptor (tlr) antagonists
|
|
AU2008352942B2
(en)
|
2007-12-19 |
2013-09-12 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof
|
|
CN101981182A
(zh)
*
|
2007-12-21 |
2011-02-23 |
惠氏有限责任公司 |
经遗传修饰减毒的疱疹性口炎病毒、其组合物和使用方法
|
|
CA2710600C
(en)
|
2007-12-24 |
2017-06-06 |
Id Biomedical Corporation Of Quebec |
Recombinant rsv antigens
|
|
WO2009126822A2
(en)
|
2008-04-09 |
2009-10-15 |
The University Of North Carolina At Chapel Hill |
Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
|
|
PL2271360T3
(pl)
|
2008-04-16 |
2016-03-31 |
Glaxosmithkline Biologicals Sa |
Szczepionka
|
|
AU2009259959A1
(en)
|
2008-06-20 |
2009-12-23 |
Wyeth Llc |
Compositions and methods of use of ORF1358 from beta-hemolytic streptococcal strains
|
|
MX2011004755A
(es)
*
|
2008-11-05 |
2011-10-10 |
Wyeth Llc |
Composicion inmunogenica multicomponente para la prevencion de enfermedad estreptococica beta-hemolitica (bhs).
|
|
KR20110091560A
(ko)
|
2008-12-03 |
2011-08-11 |
프로테아 벡신 테크놀로지스 엘티디. |
글루타밀 ｔＲＮＡ 합성효소(ＧｔＳ) 단편들
|
|
ES2552243T3
(es)
|
2008-12-23 |
2015-11-26 |
Glaxosmithkline Biologicals S.A. |
Miméticos del lípido A para su uso en la inducción de una respuesta inmunitaria
|
|
WO2010079081A1
(en)
|
2009-01-07 |
2010-07-15 |
Glaxosmithkline Biologicals S.A. |
Methods for recovering a virus or a viral antigen produced by cell culture
|
|
GB0901423D0
(en)
|
2009-01-29 |
2009-03-11 |
Secr Defence |
Treatment
|
|
GB0901411D0
(en)
|
2009-01-29 |
2009-03-11 |
Secr Defence |
Treatment
|
|
US20110293660A1
(en)
|
2009-02-06 |
2011-12-01 |
Bruno Rene Andre |
Novel method
|
|
PE20110992A1
(es)
|
2009-02-17 |
2012-02-12 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica que comprende un antigeno del virus del dengue
|
|
WO2010105815A2
(en)
|
2009-03-17 |
2010-09-23 |
Oncomethylome Sciences S.A. |
Improved detection of gene expression
|
|
AU2010233151A1
(en)
*
|
2009-04-09 |
2011-11-17 |
The University Of North Carolina At Chapel Hill |
Methods of treating edema related to ischemia-reperfusion
|
|
GB0906234D0
(en)
|
2009-04-14 |
2009-05-20 |
Secr Defence |
Vaccine
|
|
SG10201406432RA
(en)
|
2009-06-22 |
2014-11-27 |
Wyeth Llc |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
|
SI2445522T1
(sl)
|
2009-06-22 |
2017-10-30 |
Wyeth Llc |
Imunogeni sestavki antigenov Staphylococcusa aureusa
|
|
AU2010264686A1
(en)
|
2009-06-24 |
2012-01-19 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
EA023054B1
(ru)
|
2009-06-24 |
2016-04-29 |
Глэксосмитклайн Байолоджикалз С.А. |
Рекомбинантные антигены pcb
|
|
CA2803282C
(en)
|
2009-07-06 |
2018-05-01 |
David E. Anderson |
Methods for preparing vesicles and formulations produced therefrom
|
|
CN107029229B
(zh)
|
2009-07-06 |
2022-08-26 |
变异生物技术公司 |
制备囊泡的方法和由其产生的制剂
|
|
PL3178490T3
(pl)
|
2009-07-15 |
2022-08-01 |
Glaxosmithkline Biologicals S.A. |
Kompozycje białka f rsv i sposoby ich wytwarzania
|
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
GB0917457D0
(en)
|
2009-10-06 |
2009-11-18 |
Glaxosmithkline Biolog Sa |
Method
|
|
JP5774010B2
(ja)
|
2009-09-25 |
2015-09-02 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
インフルエンザウイルスのための免疫拡散アッセイ
|
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
|
WO2011067758A2
(en)
|
2009-12-02 |
2011-06-09 |
Protea Vaccine Technologies Ltd. |
Immunogenic fragments and multimers from streptococcus pneumoniae proteins
|
|
US20130039943A1
(en)
|
2010-05-03 |
2013-02-14 |
Bruno Rene Andre |
Novel method
|
|
GB201009273D0
(en)
|
2010-06-03 |
2010-07-21 |
Glaxosmithkline Biolog Sa |
Novel vaccine
|
|
AU2011262346B2
(en)
|
2010-06-04 |
2014-12-11 |
Wyeth Llc |
Streptococcus pneumoniae vaccine formulations
|
|
MX342138B
(es)
|
2010-07-06 |
2016-09-14 |
Variation Biotechnologies Inc |
Composiciones y metodos para el tratamiento de influenza.
|
|
KR101594228B1
(ko)
|
2010-08-23 |
2016-02-15 |
와이어쓰 엘엘씨 |
네이세리아 메닌기티디스 ｒＬＰ２０８６ 항원의 안정한 제제
|
|
AU2011300409B2
(en)
|
2010-09-10 |
2015-03-26 |
Wyeth Llc |
Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
|
|
GB201101331D0
(en)
|
2011-01-26 |
2011-03-09 |
Glaxosmithkline Biolog Sa |
Compositions and uses
|
|
JP5951634B2
(ja)
|
2010-12-14 |
2016-07-13 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
マイコバクテリウム抗原性組成物
|
|
RU2570730C2
(ru)
|
2010-12-22 |
2015-12-10 |
УАЙТ ЭлЭлСи |
Стабильные иммуногенные композиции антигенов staphylococcus aureus
|
|
US10736844B2
(en)
|
2011-01-13 |
2020-08-11 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
CA2828068C
(en)
|
2011-02-22 |
2019-03-19 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
KR20140023903A
(ko)
|
2011-02-24 |
2014-02-27 |
온코타이레온, 인코포레이티드 |
항원보강제를 갖는 muc1 기초 당지질펩티드 백신
|
|
AU2012257771C1
(en)
|
2011-05-17 |
2015-12-03 |
Glaxosmithkline Biologicals S.A. |
Vaccine against Streptococcus pneumoniae
|
|
BR112013031039B1
(pt)
|
2011-06-03 |
2020-04-28 |
3M Innovative Properties Co |
compostos de hidrazino 1h-imidazoquinolina-4-aminas, conjugados feitos destes compostos, composição e composição farmacêutica compreendendo ditos compostos e conjugados, usos dos mesmos e método de fabricação do conjugado
|
|
JP6460789B2
(ja)
|
2011-06-03 |
2019-01-30 |
スリーエム イノベイティブ プロパティズ カンパニー |
ポリエチレングリコールセグメントを有するヘテロ２官能性リンカー及び該リンカーから調製された免疫反応調節複合体
|
|
ITMI20111182A1
(it)
|
2011-06-28 |
2012-12-29 |
Canio Buonavoglia |
Vaccino per coronavirus canino
|
|
GB201113570D0
(en)
|
2011-08-05 |
2011-09-21 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
GB201116248D0
(en)
|
2011-09-20 |
2011-11-02 |
Glaxosmithkline Biolog Sa |
Liposome production using isopropanol
|
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
WO2013104995A2
(en)
|
2012-01-12 |
2013-07-18 |
Variation Biotechnologies, Inc. |
Compositions and methods for treating viral infections
|
|
CN104244984B
(zh)
|
2012-01-27 |
2020-03-31 |
变异生物技术公司 |
用于治疗剂的方法和组合物
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
KR101763625B1
(ko)
|
2012-03-09 |
2017-08-01 |
화이자 인코포레이티드 |
수막염균 조성물 및 이의 사용 방법
|
|
CA2866582A1
(en)
|
2012-03-18 |
2013-09-26 |
Brigitte Desiree Alberte Colau |
Method of vaccination against human papillomavirus
|
|
EP3492095A1
(en)
|
2012-04-01 |
2019-06-05 |
Technion Research & Development Foundation Limited |
Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
|
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
WO2014015091A2
(en)
|
2012-07-19 |
2014-01-23 |
Zoetis Llc |
Bovine influenza virus compositions
|
|
WO2014018724A1
(en)
|
2012-07-27 |
2014-01-30 |
Zoetis Llc |
Tick toxin compositions
|
|
CA2879939A1
(en)
|
2012-08-06 |
2014-02-13 |
Glaxosmithkline Biologicals S.A. |
Novel method
|
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
IN2015DN00694A
(hu)
|
2012-08-16 |
2015-06-26 |
Pfizer |
|
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
IL274500B2
(en)
|
2012-12-20 |
2024-01-01 |
Pfizer |
glycoconjugation process
|
|
RU2687144C2
(ru)
|
2013-02-05 |
2019-05-07 |
Нитто Денко Корпорейшн |
Композиция противораковой вакцины, содержащей пептид wt1, для трансдермального введения
|
|
JP2014169280A
(ja)
|
2013-02-05 |
2014-09-18 |
Nitto Denko Corp |
経皮または粘膜投与用ワクチン組成物
|
|
CA2841014A1
(en)
|
2013-02-05 |
2014-08-05 |
Nitto Denko Corporation |
Tape preparation of wt1 peptide cancer vaccine for transdermal administration
|
|
JP2014169275A
(ja)
|
2013-02-05 |
2014-09-18 |
Nitto Denko Corp |
粘膜投与用ワクチン組成物
|
|
IN2014CH00390A
(hu)
|
2013-02-05 |
2015-07-31 |
Nitto Denko Corp |
|
|
CA2840988A1
(en)
|
2013-02-05 |
2014-08-05 |
Nitto Denko Corporation |
Wt1 peptide cancer vaccine composition for mucosal administration
|
|
CN103961701B
(zh)
|
2013-02-05 |
2018-09-14 |
日东电工株式会社 |
疫苗组合物
|
|
KR20140100418A
(ko)
|
2013-02-05 |
2014-08-14 |
닛토덴코 가부시키가이샤 |
점막 투여용 백신 조성물
|
|
KR20140100416A
(ko)
|
2013-02-05 |
2014-08-14 |
닛토덴코 가부시키가이샤 |
경피 투여용 ｗｔ1 펩티드 암 백신 조성물
|
|
US20140220056A1
(en)
|
2013-02-05 |
2014-08-07 |
Nitto Denko Corporation |
Vaccine composition for transdermal administration
|
|
US9802987B2
(en)
|
2013-03-08 |
2017-10-31 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
CN105188710A
(zh)
|
2013-03-15 |
2015-12-23 |
葛兰素史密丝克莱恩生物有限公司 |
包含缓冲的氨基烷基氨基葡糖苷磷酸酯衍生物的组合物及其用于增强免疫应答的用途
|
|
EP2983703A1
(en)
|
2013-03-15 |
2016-02-17 |
Zoetis Services LLC |
Cross-protection of bovines against b. trehalosi infection by a multi-valent vaccine
|
|
EP2968521A2
(en)
|
2013-03-15 |
2016-01-20 |
GlaxoSmithKline Biologicals S.A. |
Vaccine
|
|
WO2014160987A2
(en)
|
2013-03-28 |
2014-10-02 |
Infectious Disease Research Institute |
Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
|
|
WO2014183066A2
(en)
|
2013-05-10 |
2014-11-13 |
Whitehead Institute For Biomedical Research |
Protein modification of living cells using sortase
|
|
SG11201600709TA
(en)
|
2013-08-05 |
2016-02-26 |
Glaxosmithkline Biolog Sa |
Combination immunogenic compositions
|
|
US10392603B2
(en)
|
2013-08-30 |
2019-08-27 |
The Chemo-Sero-Therapeutic Research Institute |
Method of viral purification
|
|
US9822150B2
(en)
|
2013-09-08 |
2017-11-21 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
JP2015059577A
(ja)
|
2013-09-17 |
2015-03-30 |
Ntn株式会社 |
チェーン伝動装置
|
|
CN104436157A
(zh)
|
2013-09-23 |
2015-03-25 |
恩金生物有限公司 |
流感疫苗和治疗
|
|
WO2015092710A1
(en)
|
2013-12-19 |
2015-06-25 |
Glaxosmithkline Biologicals, S.A. |
Contralateral co-administration of vaccines
|
|
US11708411B2
(en)
|
2013-12-20 |
2023-07-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
|
CN105934251A
(zh)
|
2014-01-21 |
2016-09-07 |
辉瑞大药厂 |
肺炎链球菌荚膜多糖及其缀合物
|
|
PT3096786T
(pt)
|
2014-01-21 |
2021-08-24 |
Pfizer |
Polissacáridos capsulares de streptococcus pneumoniae e conjugados dos mesmos
|
|
WO2016130569A1
(en)
|
2015-02-09 |
2016-08-18 |
Mj Biologics, Inc. |
A composition comprising pedv antigens and methods for making and using the composition
|
|
JP2017505792A
(ja)
|
2014-02-14 |
2017-02-23 |
ファイザー・インク |
免疫原性糖タンパク質コンジュゲート
|
|
WO2015130584A2
(en)
|
2014-02-25 |
2015-09-03 |
Merck Sharp & Dohme Corp. |
Lipid nanoparticle vaccine adjuvants and antigen delivery systems
|
|
EP3116539B1
(en)
|
2014-03-11 |
2018-10-10 |
Regents of the University of Minnesota |
Porcine epidemic diarrhea virus vaccines and methods of use thereof
|
|
US20170071967A1
(en)
|
2014-03-12 |
2017-03-16 |
Glaxosmithkline Biologicals, Sa |
Immunogenic liposomal formulation
|
|
CA2942234A1
(en)
|
2014-03-12 |
2015-09-17 |
Glaxosmithkline Biologicals S.A. |
Liposomal compositions for mucosal delivery
|
|
EP3125931A4
(en)
|
2014-04-03 |
2017-09-20 |
Biondvax Pharmaceuticals Ltd. |
Compositions of multimeric-multiepitope influenza polypeptides and their production
|
|
CA2951430A1
(en)
|
2014-06-13 |
2015-12-17 |
Glaxosmithkline Biologicals Sa |
Immunogenic combinations
|
|
WO2016012385A1
(en)
|
2014-07-21 |
2016-01-28 |
Sanofi Pasteur |
Vaccine composition comprising ipv and cyclodextrins
|
|
MA40920A
(fr)
|
2014-11-07 |
2017-09-12 |
Takeda Vaccines Inc |
Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
|
|
AR102548A1
(es)
|
2014-11-07 |
2017-03-08 |
Takeda Vaccines Inc |
Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y uso
|
|
EP3242883A4
(en)
|
2015-01-06 |
2018-10-17 |
ImmunoVaccine Technologies Inc. |
Lipid a mimics, methods of preparation, and uses thereof
|
|
MA41414A
(fr)
|
2015-01-28 |
2017-12-05 |
Centre Nat Rech Scient |
Protéines de liaison agonistes d' icos
|
|
KR20170103009A
(ko)
|
2015-02-19 |
2017-09-12 |
화이자 인코포레이티드 |
나이세리아 메닌지티디스 조성물 및 그의 방법
|
|
WO2016140702A1
(en)
|
2015-03-03 |
2016-09-09 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Serivces |
Display platform from bacterial spore coat proteins
|
|
CA2979541C
(en)
|
2015-03-12 |
2019-07-16 |
Zoetis Services Llc |
Pyolysin methods and compositions
|
|
EP3292146A1
(en)
|
2015-05-04 |
2018-03-14 |
Pfizer Inc |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
RU2017140856A
(ru)
|
2015-05-26 |
2019-06-26 |
Огайо Стейт Инновейшн Фаундейшн |
Стратегия вакцинации против вируса свиного гриппа вакциной на основе наночастиц
|
|
TW201716084A
(zh)
|
2015-08-06 |
2017-05-16 |
葛蘭素史克智慧財產發展有限公司 |
組合物及其用途與治療
|
|
CA2994790A1
(en)
|
2015-08-06 |
2017-02-09 |
Christopher W. Cluff |
Tlr4 agonists and compositions thereof and their use in the treatment of cancer
|
|
WO2017021912A1
(en)
|
2015-08-06 |
2017-02-09 |
Glaxosmithkline Intellectual Property Development Limited |
Combined tlrs modulators with anti ox40 antibodies
|
|
LT3334454T
(lt)
|
2015-08-14 |
2022-12-27 |
Zoetis Services Llc |
Mycoplasma bovis kompozicijos
|
|
WO2017059280A1
(en)
|
2015-10-02 |
2017-04-06 |
The University Of North Carolina At Chapel Hill |
Novel pan-tam inhibitors and mer/axl dual inhibitors
|
|
CA3000591A1
(en)
|
2015-10-13 |
2017-04-20 |
Sanofi Pasteur |
Immunogenic compositions against s. aureus
|
|
MA44334A
(fr)
|
2015-10-29 |
2018-09-05 |
Novartis Ag |
Conjugués d'anticorps comprenant un agoniste du récepteur de type toll
|
|
EP3322713B1
(en)
|
2015-12-03 |
2021-01-20 |
GlaxoSmithKline Intellectual Property Development Limited |
Cyclic purine dinucleotides as modulators of sting
|
|
WO2017098421A1
(en)
|
2015-12-08 |
2017-06-15 |
Glaxosmithkline Intellectual Property Development Limited |
Benzothiadiazine compounds
|
|
US20180318415A1
(en)
|
2015-12-08 |
2018-11-08 |
Glaxosmithkline Biologicals, Sa |
Novel adjuvant formulations
|
|
CA3010977A1
(en)
|
2016-01-11 |
2017-07-20 |
Zoetis Services Llc |
Novel cross protective vaccine compositions for porcine epidemic diarrhea virus
|
|
WO2017137085A1
(en)
|
2016-02-11 |
2017-08-17 |
Sanofi Pasteur |
Meningitidis vaccines comprising subtilinases
|
|
WO2017153952A1
(en)
|
2016-03-10 |
2017-09-14 |
Glaxosmithkline Intellectual Property Development Limited |
5-sulfamoyl-2-hydroxybenzamide derivatives
|
|
MX2018012333A
(es)
|
2016-04-07 |
2019-03-07 |
Glaxosmithkline Ip Dev Ltd |
Amidas heterociclicas utiles como moduladores de proteinas.
|
|
RU2018137389A
(ru)
|
2016-04-07 |
2020-05-12 |
Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Гетероциклические амиды, полезные в качестве модуляторов
|
|
CA3023157A1
(en)
|
2016-05-05 |
2017-11-09 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Enhancer of zeste homolog 2 inhibitors
|
|
US11033615B2
(en)
|
2016-05-31 |
2021-06-15 |
The Government of the United States, As Represented by the Secretary of the Army Fort Detrick, Maryland |
Zika virus vaccine and methods of production
|
|
EP3474890A1
(en)
|
2016-06-22 |
2019-05-01 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften E. V. |
Pneumococcal polysaccharide-protein conjugate composition
|
|
EP3269385A1
(en)
|
2016-07-12 |
2018-01-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
|
CN109789135A
(zh)
|
2016-07-20 |
2019-05-21 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为perk抑制剂的异喹啉衍生物
|
|
EP3504230A1
(en)
|
2016-08-23 |
2019-07-03 |
GlaxoSmithKline Biologicals SA |
Fusion peptides with antigens linked to short fragments of invariant chain (cd74)
|
|
US11801290B2
(en)
|
2016-09-16 |
2023-10-31 |
Access To Advanced Health Institute |
Vaccines comprising Mycobacterium leprae polypeptides for the prevention, treatment, and diagnosis of leprosy
|
|
WO2018060288A1
(en)
|
2016-09-29 |
2018-04-05 |
Glaxosmithkline Biologicals S.A. |
Compositions and methods of treatment of persistent hpv infection
|
|
GB201616904D0
(en)
|
2016-10-05 |
2016-11-16 |
Glaxosmithkline Biologicals Sa |
Vaccine
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
EP3548638A1
(en)
|
2016-12-01 |
2019-10-09 |
GlaxoSmithKline Intellectual Property Development Limited |
Methods of treating cancer
|
|
US10695424B2
(en)
|
2016-12-07 |
2020-06-30 |
Glaxosmithkline Biologicals S.A. |
Method of making a liposome composition
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
US11084850B2
(en)
|
2016-12-16 |
2021-08-10 |
The Pirbright Institute |
Recombinant prefusion RSV F proteins and uses thereof
|
|
GB201621686D0
(en)
|
2016-12-20 |
2017-02-01 |
Glaxosmithkline Biologicals Sa |
Novel methods for inducing an immune response
|
|
PE20191107A1
(es)
|
2017-01-31 |
2019-08-26 |
Pfizer |
Composiciones de neisseria meningitidis y metodos respectivos
|
|
WO2018144438A1
(en)
|
2017-01-31 |
2018-08-09 |
Merck Sharp & Dohme Corp. |
Methods for production of capsular polysaccharide protein conjugates from streptococcus pneumoniae serotype 19f
|
|
GB201703529D0
(en)
|
2017-03-06 |
2017-04-19 |
Cambridge Entpr Ltd |
Vaccine composition
|
|
WO2018183666A1
(en)
|
2017-03-31 |
2018-10-04 |
Boston Medical Center Corporation |
Methods and compositions using highly converved pneumococcal surface proteins
|
|
KR102595238B1
(ko)
|
2017-04-19 |
2023-10-26 |
인스티튜트 포 리서치 인 바이오메드슨 |
말라리아원충 종충에 결합하는 신규한 말라리아 백신 및 항체.
|
|
WO2018198085A1
(en)
|
2017-04-28 |
2018-11-01 |
Glaxosmithkline Biologicals Sa |
Vaccination
|
|
US11389465B2
(en)
|
2017-05-01 |
2022-07-19 |
Vanderbilt University |
Phosphorylated hexaacyl disaccharides (PHADs) for treating or preventing infections
|
|
GB201707700D0
(en)
|
2017-05-12 |
2017-06-28 |
Glaxosmithkline Biologicals Sa |
Dried composition
|
|
BR112019025193A2
(pt)
|
2017-05-30 |
2020-06-23 |
Glaxosmithkline Biologicals S.A. |
Métodos de fabricação de um adjuvante lipossomal, de fabricação de um concentrado lipossomal, para a preparação de uma composição imunogênica com adjuvante e para a preparação de uma solução, adjuvante lipossomal, composição imunogênica com adjuvante, e, solução
|
|
CN111065417B
(zh)
|
2017-06-23 |
2024-04-19 |
美商艾芬尼维克斯公司 |
免疫原性组合物
|
|
WO2019021208A1
(en)
|
2017-07-27 |
2019-01-31 |
Glaxosmithkline Intellectual Property Development Limited |
USEFUL INDAZOLE DERIVATIVES AS PERK INHIBITORS
|
|
CN111093650B
(zh)
|
2017-09-07 |
2024-03-01 |
默沙东有限责任公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
|
WO2019053617A1
(en)
|
2017-09-12 |
2019-03-21 |
Glaxosmithkline Intellectual Property Development Limited |
CHEMICAL COMPOUNDS
|
|
KR20200051778A
(ko)
|
2017-09-13 |
2020-05-13 |
사노피 파스퇴르 |
인간 시토메갈로바이러스 면역원성 조성물
|
|
EP3692033A1
(en)
|
2017-10-05 |
2020-08-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (sting) useful in treating hiv
|
|
CA3077337A1
(en)
|
2017-10-05 |
2019-04-11 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (sting)
|
|
JP7197880B2
(ja)
*
|
2017-10-19 |
2022-12-28 |
学校法人 名城大学 |
エステル化剤及びその利用
|
|
CN117982633A
(zh)
|
2017-12-06 |
2024-05-07 |
默沙东有限责任公司 |
包含肺炎链球菌多糖蛋白缀合物的组合物及其使用方法
|
|
MX2020008417A
(es)
|
2018-02-12 |
2020-11-11 |
Inimmune Corp |
Ligandos de receptores de tipo toll.
|
|
JP7448954B2
(ja)
|
2018-02-21 |
2024-03-13 |
ザ ユニバーシティー オブ モンタナ |
ジアリールトレハロース化合物及びその使用
|
|
RU2020128440A
(ru)
|
2018-02-28 |
2022-03-28 |
Пфайзер Инк. |
Варианты il-15 и их применения
|
|
WO2019169313A1
(en)
|
2018-03-02 |
2019-09-06 |
The University Of Montana |
Immunogenic trehalose compounds and uses thereof
|
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
|
EP3797121A1
(en)
|
2018-05-23 |
2021-03-31 |
Pfizer Inc |
Antibodies specific for cd3 and uses thereof
|
|
CN113286634A
(zh)
|
2018-05-23 |
2021-08-20 |
辉瑞公司 |
对gucy2c特异性的抗体及其用途
|
|
EP3574915A1
(en)
|
2018-05-29 |
2019-12-04 |
Neovacs |
Immunogenic product comprising il-4 and/or il-13 for treating disorders associated with aberrant il-4 and/or il 13 expression or activity
|
|
US11702674B2
(en)
|
2018-06-12 |
2023-07-18 |
Glaxosmithkline Biologicals Sa |
Simian adenovirus vectors comprising the ChAd-157 fiber protein
|
|
EP3581201A1
(en)
|
2018-06-15 |
2019-12-18 |
GlaxoSmithKline Biologicals S.A. |
Escherichia coli o157:h7 proteins and uses thereof
|
|
AU2019313502A1
(en)
|
2018-07-31 |
2021-01-28 |
Glaxosmithkline Biologicals Sa |
Antigen purification method
|
|
WO2020030571A1
(en)
|
2018-08-06 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Combinations of a pd-1 antibody and a tlr4 modulator and uses thereof
|
|
WO2020030570A1
(en)
|
2018-08-06 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Combinations of an ox40 antibody and a tlr4 modulator and uses thereof
|
|
WO2020031087A1
(en)
|
2018-08-06 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Combination therapy
|
|
US20220118077A1
(en)
|
2018-09-11 |
2022-04-21 |
Shanghai Public Health Clinical Center |
Immunogen for broad-spectrum influenza vaccine and application thereof
|
|
EP3886901A1
(en)
|
2018-11-29 |
2021-10-06 |
GlaxoSmithKline Biologicals S.A. |
Methods for manufacturing an adjuvant
|
|
SG11202106541WA
(en)
|
2018-12-19 |
2021-07-29 |
Merck Sharp & Dohme |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
WO2020128893A1
(en)
|
2018-12-21 |
2020-06-25 |
Pfizer Inc. |
Combination treatments of cancer comprising a tlr agonist
|
|
WO2020128012A1
(en)
|
2018-12-21 |
2020-06-25 |
Glaxosmithkline Biologicals Sa |
Methods of inducing an immune response
|
|
CA3138461A1
(en)
|
2019-05-23 |
2020-11-26 |
Helene Bazin-Lee |
Vaccine adjuvants based on tlr receptor ligands
|
|
CA3143211A1
(en)
|
2019-06-26 |
2020-12-30 |
Glaxosmithkline Intellectual Property Development Limited |
Il1rap binding proteins
|
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
EP3999093A4
(en)
|
2019-07-19 |
2023-11-22 |
Merck Sharp & Dohme LLC |
ANTIGEN GLYCOPROTEIN E POLYPEPTIDES, COMPOSITIONS AND METHODS OF USE THEREOF
|
|
CN114206909A
(zh)
|
2019-07-21 |
2022-03-18 |
葛兰素史克生物有限公司 |
治疗性病毒疫苗
|
|
AU2020323498A1
(en)
|
2019-07-31 |
2022-03-03 |
Sk Bioscience Co., Ltd. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
|
WO2021018941A1
(en)
|
2019-07-31 |
2021-02-04 |
Glaxosmithkline Intellectual Property Development Limited |
Methods of treating cancer
|
|
WO2021043961A1
(en)
|
2019-09-06 |
2021-03-11 |
Glaxosmithkline Intellectual Property Development Limited |
Dosing regimen for the treatment of cancer with an anti icos agonistic antibody and chemotherapy
|
|
US20210069321A1
(en)
|
2019-09-09 |
2021-03-11 |
Glaxosmithkline Biologicals Sa |
Immunotherapeutic compositions
|
|
CN114729049A
(zh)
|
2019-09-27 |
2022-07-08 |
葛兰素史密斯克莱知识产权发展有限公司 |
抗原结合蛋白
|
|
US20220387614A1
(en)
|
2019-11-22 |
2022-12-08 |
Glaxosmithkline Biologicals Sa |
Dosage and administration of a bacterial saccharide glycoconjugate vaccine
|
|
CA3164623A1
(en)
|
2019-12-17 |
2021-06-24 |
Pfizer Inc. |
Antibodies specific for cd47, pd-l1, and uses thereof
|
|
WO2021163448A2
(en)
|
2020-02-13 |
2021-08-19 |
The Board Of Trustees Of The University Of Illinois |
Vaccine and methods for detecting and preventing filariasis
|
|
US20230233652A1
(en)
|
2020-04-16 |
2023-07-27 |
Par'immune Sas |
28 kda gst proteins from schistosoma for the treatment of vasculitis
|
|
WO2021211279A1
(en)
|
2020-04-17 |
2021-10-21 |
Regents Of The University Of Minnesota |
SARS-CoV-2 SPIKE RECEPTOR BINDING DOMAIN AND COMPOSITIONS AND METHODS THEREOF
|
|
EP3900739A1
(en)
|
2020-04-21 |
2021-10-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Synthetic streptococcus pneumoniae saccharide conjugates to conserved membrane protein
|
|
US20230277657A1
(en)
|
2020-05-05 |
2023-09-07 |
Glaxosmithkline Biologicals Sa |
Microfluidic mixing device and methods of use
|
|
EP4158352A1
(en)
|
2020-06-01 |
2023-04-05 |
Loop Diagnostics, S.L. |
Method and kit for the early detection of sepsis
|
|
US20230234992A1
(en)
|
2020-06-05 |
2023-07-27 |
Glaxosmithkline Biologicals Sa |
Modified betacoronavirus spike proteins
|
|
PE20230463A1
(es)
|
2020-06-22 |
2023-03-14 |
Sumitomo Pharma Co Ltd |
Adyuvante con actividad agonista del receptor tipo toll 4 (tlr4)
|
|
CA3189590A1
(en)
|
2020-07-17 |
2022-01-20 |
Pfizer Inc. |
Therapeutic antibodies and their uses
|
|
EP4203995A1
(en)
|
2020-08-26 |
2023-07-05 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
EP4213943A1
(en)
|
2020-09-15 |
2023-07-26 |
The University Of Montana |
Compositions and methods targeting filamentous bacteriophage
|
|
AU2021343290A1
(en)
|
2020-09-17 |
2023-04-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Immunogenic product comprising an IgE fragment for treating IgE-mediated inflammatory disorders
|
|
TW202233200A
(zh)
|
2020-11-11 |
2022-09-01 |
日商第一三共股份有限公司 |
新穎胺基烷基葡萄胺糖苷4-磷酸衍生物
|
|
IL303334A
(en)
|
2020-12-02 |
2023-07-01 |
Glaxosmithkline Biologicals Sa |
The perfect fimh by a donor strand
|
|
EP4032547A1
(en)
|
2021-01-20 |
2022-07-27 |
GlaxoSmithKline Biologicals S.A. |
Hsv1 fce derived fragements for the treatment of hsv
|
|
AU2022218139A1
(en)
|
2021-02-03 |
2023-09-21 |
Pai Life Sciences Inc. |
Vaccine and methods for preventing filariasis and dirofilariasis
|
|
CA3210363A1
(en)
|
2021-02-11 |
2022-08-18 |
Glaxosmithkline Biologicals Sa |
Hpv vaccine manufacture
|
|
CA3212345A1
(en)
|
2021-03-02 |
2022-09-09 |
Glaxosmithkline Intellectual Property Development Limited |
Substituted pyridines as dnmt1 inhibitors
|
|
WO2022208353A1
(en)
|
2021-03-31 |
2022-10-06 |
Glaxosmithkline Intellectual Property Development Limited |
Antigen binding proteins and combinations thereof
|
|
WO2023020993A1
(en)
|
2021-08-16 |
2023-02-23 |
Glaxosmithkline Biologicals Sa |
Novel methods
|
|
WO2023020992A1
(en)
|
2021-08-16 |
2023-02-23 |
Glaxosmithkline Biologicals Sa |
Novel methods
|
|
WO2023020994A1
(en)
|
2021-08-16 |
2023-02-23 |
Glaxosmithkline Biologicals Sa |
Novel methods
|
|
WO2023114727A1
(en)
|
2021-12-13 |
2023-06-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Bacteriophage lambda-vaccine system
|
|
CN114318353B
(zh)
*
|
2021-12-27 |
2023-12-05 |
广东红日星实业有限公司 |
一种除灰剂及其制备方法和应用
|
|
WO2024069420A2
(en)
|
2022-09-29 |
2024-04-04 |
Pfizer Inc. |
Immunogenic compositions comprising an rsv f protein trimer
|